Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Reviewing Verastem's recent Phase I/II data investigating their kinase inhibitor, avutometinib, for the treatment of metastatic pancreatic cancer

Ticker(s): VSTM

Who's the expert?

Institution: Duke University

Gastrointestinal Oncologist and Professor of Medicine in the Department of Surgery at Duke University
Manages 30+ patients with pancreatic cancer
Research interest in immune therapies for treating GI cancers

Interview Goal

Discussing the standard of care for pancreatic cancer and the Phase I/II results of avutometinib

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.